Brain games and tai chi tested as new weapons against Early-Onset Alzheimer's

NCT ID NCT05573490

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study tests whether computerized brain training (BrainHQ) and Tai Chi-Qi Gong can improve memory, thinking, and mood in people with early-onset Alzheimer's disease. Sixty participants aged 40-64 will complete either the training or an active control condition over 14 weeks. Researchers will measure memory and executive function immediately after and 26 weeks later to see if the interventions provide lasting benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE, EARLY ONSET are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Indiana University

    RECRUITING

    Indianapolis, Indiana, 46202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Computerized cognitive training (BrainHQ) and Tai Chi-Qi Gong

What this could lead to

If it works, this could point toward a non-drug way to help people with early-onset Alzheimer's keep their memory and thinking skills longer.

What could go wrong

This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The training is time-consuming, and there is no guarantee it will improve symptoms.

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.